Ursodeoxycholic acid for coronavirus disease 2019 prevention
J Intern Med
.
2024 Jan;295(1):106-109.
doi: 10.1111/joim.13704.
Epub 2023 Jul 27.
Authors
Kazuya Okushin
1
2
,
Makoto Kurano
3
4
;
UTH-UDCA Study Group
1
;
Yutaka Yatomi
3
4
,
Kyoji Moriya
1
,
Mitsuhiro Fujishiro
2
,
Takeya Tsutsumi
1
Affiliations
1
Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
2
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
3
Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
4
Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
PMID:
37470083
DOI:
10.1111/joim.13704
No abstract available
Publication types
Letter
MeSH terms
Bile Acids and Salts
COVID-19*
Humans
Ursodeoxycholic Acid* / therapeutic use
Substances
Ursodeoxycholic Acid
Bile Acids and Salts